Cytology Brushes Market - Growth, Trends And Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 928011
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
細胞診斷刷的全球市場:成長,趨勢,預測(2020年∼2025年) Cytology Brushes Market - Growth, Trends And Forecast (2020 - 2025)
出版日期: 2020年03月01日內容資訊: 英文 111 Pages




第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 慢性疾病的盛行率增加
    • 細胞診斷刷的技術進步
  • 阻礙市場要素
    • 細胞診斷的靈敏度低
  • 波特的五力分析

第5章 市場細分化

  • 各產品
    • 金屬細胞診斷刷
    • 塑膠細胞診斷刷
  • 各用途
    • 呼吸道
    • 腸胃
    • 婦產科
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Boston Scientific Corporation
    • Conmed Corporation
    • Cook
    • Cosmomed SA
    • Endomed Systems
    • Medgyn Products, Inc.
    • Medi-Globe Gmbh
    • Olympus America
    • Telemed Systems, Inc.

第7章 市場機會及未來趨勢

Product Code: 68372

The global cytology brushes market studied was anticipated to grow with a CAGR of nearly 5.2% during the forecast period. Growing prevalence of various lifestyle associated with chronic diseases such as urological disorders & cancer and increasing emphasis on early detection are some of the factors expected to drive the overall market growth. According to the World Health Organization, Globally, cervical cancer is the fourth most frequent cancer in women with an estimated 570,000 new cases in 2018 representing 6.6% of all female cancers. The requirement of cytology brush for collection of exfoliated cell samples is mounting due to growing occurrence of chronic diseases worldwide. They are critical during cancer screening as it supports precise cell collection, accurate examination, and reliable diagnostics by reducing intervention time and risk. It is the safest, simplest, and quickest means of diagnosing diseases through analysis at a cellular level. Thus, broader range of application of these brushes govern the market growth.

Technological advancements such as effective in collecting specimens from the endo-cervical region, tiny nylon bristles and soft brush head measures is a pivotal aspect.

The tendency of the older population being prone to diseases such as urinary incontinence, respiratory ailments and increasing patient population base is likely to augment market demand. Government bodies play a critical part in the growth of the product market as they facilitate increase in demand by spending in health infrastructure, crafting improved reimbursement packages, setting competitive prices and encouraging research and development. Improvements in medical standards & facilities, changing technological trends are factors expected to promote growth in this market.

However, inadequacy in skilled professionals to perform sample collections using cytology brushes may restrict the market.

Key Market Trends

Gynecological Segment Dominates the Market and is Expected to Continue to Do the Same during the Forecast Period

  • Gynecological segment is expected to dominate the global cytology brush market through the forecast period. Growing prevalence of gynecological diseases and conditions such as cervical cancer, uterine cancer, polycystic ovary syndrome, vaginal melanoma, extended bleeding, and irregular menstrual cycles are primarily resulting in increased demand for cytology brush in the gynecological treatments.
  • As per the American Society of Clinical Oncology, in 2019 over 12,590 women died due to uterine or endometrial cancer in the United States. Rising awareness and preventive check-ups to avoid late phase diagnosis are estimated to increase the number of visits. This, in turn, will stir up the demand for cytology brushes.
  • Furthermore, soaring volume of surgical procedures with growing usage of single-use products, is expected to bolster the demand for these products. Frequent introduction of technically advanced products is likely to spur the growth of the segment over the forecast period.

North America Represents the Largest Market and Asia-Pacific is Expected to Register Fastest Growth.

North America dominates the market and it is expected to maintain its dominance throughout the forecast period. Significant awareness about chronic ailments and regular health screening, favorable government reimbursement policies, and availability of sophisticated healthcare infrastructure are key factors promoting the use of cytology brush in the North America region.

In addition, U.S. exhibits a large pool of local manufacturers offering a vast portfolio of product developed specifically for cytology applications. Furthermore, approvals and commercialization of products in the region, R&D activities by educational institutes and industry players, and high healthcare spending are some secondary factors contributing to the revenue generated in this region.

Asia Pacific is anticipated to witness a lucrative growth over the forecast period. Due to large geriatric population, unhealthy lifestyle, and socioeconomic conditions, there is high incidence of chronic diseases across the Asia Pacific region. Hence, larger target population, increase in awareness about screening, and investment of multinational companies in this region are some of the factors expected to boost the regional market growth in the coming years.

Competitive Landscape

This industry is highly fragmented with presence of several local players. The major players include companies such as Boston Scientific Corporation, Conmed Corporation, Cook, Olympus America, Telemed Systems, Inc.

These companies are actively involved in product innovations and technological advancements, to ensure better recognition and push product sales. For example, Boston Scientific Corporation launched RX Cytology Brush. It is wire guided cytology Brush having double-lumen wire guided catheter for the collection of cells and the detection of malignant neoplasms in the biliary duct.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Assumptions
  • 1.2 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases
    • 4.2.2 Technological Advancements in Cytology Brushes
  • 4.3 Market Restraints
    • 4.3.1 Low sensitivity of cytology tests
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product
    • 5.1.1 Metal Cytology Brushes
    • 5.1.2 Plastic Cytology Brushes
  • 5.2 By Application
    • 5.2.1 Respiratory Tract
    • 5.2.2 Gastro Intestinal
    • 5.2.3 Gynecological
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Conmed Corporation
    • 6.1.3 Cook
    • 6.1.4 Cosmomed S.A
    • 6.1.5 Endomed Systems
    • 6.1.6 Medgyn Products, Inc.
    • 6.1.7 Medi-Globe Gmbh
    • 6.1.8 Olympus America
    • 6.1.9 Telemed Systems, Inc.